stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Spyre Therapeutics IncSYRE
$96.562.43%-2.40

Spyre Therapeutics Inc (SYRE)

Date: 2026-10-30 16:00O: 96.78H: 98.96L: 94.68C: 96.56Vol: 658.5k
Precedente Chiudi:
$98.96
Aprire:
$96.78
Volume 24 ore:
658,464
Volume relativo:
0.73
Capitalizzazione di mercato:
$9.02B
Reddito:
$688.00K
Utile/perdita netta:
-$168.74M
Rapporto P/E:
-
EPS:
-$2.36
Flusso di cassa netto:
-$185.87M
1W Prestazione:
+6.90%
1M Prestazione:
+8.46%
6M Prestazione:
+29.70%
1Y Prestazione:
+298.02%
Intervallo 1D:
$94.68$98.96
Intervallo di 1 settimana:
$90.35$100.42
Portata 52W:
$21.15$110.18

Profilo aziendale di Spyre Therapeutics Inc (SYRE)

Nome
Spyre Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(617) 651-5940
Indirizzo
221 CRESCENT STREET, WALTHAM, USA
Dipendente
102
X
-
Prossima data di guadagno
2026-11-03
Ultimi documenti SEC
SEC
Discussioni di SYRE su X
X

Confronta SYRE con VRTX, REGN, MRNA, ARGX, ONC

AzioniPrezzoCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
SYRE
Spyre Therapeutics Inc
$96.56$9.02B$688.00K-$168.74M-$185.87M-$2.36
VRTX
Vertex Pharmaceuticals Inc
$558.88$141.65B$12.34B$4.34B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$927.89$95.53B$14.92B$4.42B$3.79B$41.04
MRNA
Moderna Inc
$221.72$88.52B$2.23B-$3.19B-$1.60B-$8.15
ARGX
Argen X Se Adr
$892.87$56.15B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$370.33$41.89B$5.76B$514.49M$1.10B$4.48

Spyre Therapeutics Inc Azioni (SYRE) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-12IniziatoUBSBuy
2026-10-01IniziatoJP MorganOverweight
2026-07-28DowngradeWolfe ResearchOutperform → Peer Perform
2026-04-14IniziatoRaymond JamesStrong Buy

Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Spyre Therapeutics Inc Azioni (SYRE) insider trading

  • Burrows Scott LOct 01 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $91.83
    #Azioni
    7,500
    Valore ($)
    688,756
    #Azioni Totale
    79,762
  • CAMERON TURTLEOct 01 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $89.03
    #Azioni
    45,000
    Valore ($)
    4,006,350
    #Azioni Totale
    0
  • See Remarks
    Transazione
    Sale
    Costo
    $91.03
    #Azioni
    28,933
    Valore ($)
    2,633,902
    #Azioni Totale
    2,845
  • Officer
    Transazione
    Proposed Sale
    Costo
    $89.03
    #Azioni
    29,335
    Valore ($)
    2,611,695
    #Azioni Totale
    0
  • Turtle CameronOct 01 '26
    Chief Executive Officer
    Transazione
    Sale
    Costo
    $92.01
    #Azioni
    15,000
    Valore ($)
    1,380,105
    #Azioni Totale
    537,540
  • Burrows Scott LOct 01 '26
    Chief Financial Officer
    Transazione
    Option Exercise
    Costo
    $14.50
    #Azioni
    7,500
    Valore ($)
    108,750
    #Azioni Totale
    87,262
  • Burrows Scott LSep 30 '26
    Chief Financial Officer
    Transazione
    Option Exercise
    Costo
    $14.50
    #Azioni
    17,500
    Valore ($)
    253,750
    #Azioni Totale
    97,262
  • SCOTT BURROWSSep 30 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $89.89
    #Azioni
    17,500
    Valore ($)
    1,573,157
    #Azioni Totale
    0
  • Burrows Scott LSep 30 '26
    Chief Financial Officer
    Transazione
    Sale
    Costo
    $89.89
    #Azioni
    17,500
    Valore ($)
    1,573,075
    #Azioni Totale
    79,762
  • See Remarks
    Transazione
    Sale
    Costo
    $90.00
    #Azioni
    400
    Valore ($)
    36,000
    #Azioni Totale
    2,845
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Burrows Scott LChief Financial OfficerOct 01 '26Sale$91.837,500688,75679,762
CAMERON TURTLEDirectorOct 01 '26Proposed Sale$89.0345,0004,006,3500
King-Jones HeidySee RemarksOct 01 '26Sale$91.0328,9332,633,9022,845
HEIDY KING-JONESOfficerOct 01 '26Proposed Sale$89.0329,3352,611,6950
Turtle CameronChief Executive OfficerOct 01 '26Sale$92.0115,0001,380,105537,540
Burrows Scott LChief Financial OfficerOct 01 '26Option Exercise$14.507,500108,75087,262
Burrows Scott LChief Financial OfficerSep 30 '26Option Exercise$14.5017,500253,75097,262
SCOTT BURROWSOfficerSep 30 '26Proposed Sale$89.8917,5001,573,1570
Burrows Scott LChief Financial OfficerSep 30 '26Sale$89.8917,5001,573,07579,762
King-Jones HeidySee RemarksSep 02 '26Sale$90.0040036,0002,845

Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie

Oct 19, 2026
Oct 19, 2026
Oct 18, 2026
Oct 18, 2026
Oct 18, 2026
Oct 18, 2026
Oct 17, 2026
Oct 17, 2026
Oct 12, 2026
Oct 12, 2026
Oct 08, 2026
Oct 08, 2026
Oct 07, 2026
Oct 07, 2026
Oct 06, 2026
Oct 06, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 30, 2026
Sep 30, 2026
Sep 23, 2026
Sep 23, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026

Simile a SYRE